JP Morgan Chase’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-36,000
Closed -$1.53M – 5067
2017
Q1
$1.53M Hold
36,000
– – ﹤0.01% 3190
2016
Q4
$1.46M Buy
+36,000
New +$1.39M ﹤0.01% 3263

Other funds holding HQY

JP Morgan Chase's HQY Position: Q2 2026 in Review

JP Morgan Chase reduced its HealthEquity (HQY) stake by 2.1% in Q2 2026, selling an estimated $2.08M and leaving 1,158,837 shares worth $102M. The position accounts for 0.01% of the portfolio, ranked #1060.

JP Morgan Chase first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $180M in Q1 2022. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • JP Morgan Chase held 1,158,837 shares of HealthEquity worth $102M as of Q2 2026.
  • JP Morgan Chase sold 24,574 HealthEquity shares in Q2 2026, an estimated $2.08M.
  • HealthEquity made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1060 holding.
  • JP Morgan Chase first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • JP Morgan Chase's HealthEquity position peaked at $180M in Q1 2022.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.